Abstract
Affective disorders are defined by their human symptoms. These symptoms, which are based on subtle behavioural and perceptual changes, are very difficult, if not impossible, to transfer to animals. How, for example, is one to recognise a depressed mouse or an anxious rat? In comparison with disorders which have a simple organic manifestation, such as hypertension, the establishment of an animal model for an affective disorder is extremely difficult. For this reason there are as yet no general screening tests for drugs active in affective disorders. The tests currently used are based on a single aspect of the drugs successful in the treatment of the depression. For instance, the inhibition of reserpine ptosis in the rat is widely used as a test for potential antidepressant activity. This test selects simply for drugs with a direct or indirect noradrenergic-agonist activity, which is a property of many, but certainly not all, clinically effective antidepressant drugs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arbilla, S., Briley, M., Cathalu, F., Langer, S.Z., Porain, C. and Raisman, R. (1981) Brit. J. Pharmacol. (in press)
Asberg, M., Bertilsson, L., Tuck, D., Cronholm, B. and Sjoqvist, F. (1973). Clin. Pharmacol. Ther., 14, 277
Asberg, M., Thoren, P., Traskman, L., Bertilsson, L. and Ringberger, V. (1976). Science 191, 478
Banerjee, S.P., King, L.S., Riggi, S.J. and Chanda, S.K. (1977). Nature 268, 455
Beigon, A. and Samuel, D. (1980a). Biochem. Pharmacol., 29, 460
Beigon, A. and Samuel, D. (1980b). Biochem. Pharmacol. (in press)
Bergstrom, D.A. and Kellar, K.J. (1979a). J. Pharmacol. Exp. Ther., 209, 256
Bergstrom, D.A. and Kellar, K.J. (1979b). Nature 278, 464
Briley, M.S., Raisman, R. and Langer S.Z. (1979). Eur. J. Pharmacol, 58, 347
Briley, M., Raisman, R., Sechter, D., Zarifian, E. and Langer, S.Z. (1980a). Neuropharmacology, 19, 209
Briley, M.S., Langer, S.Z., Raisman, R., Sechter, D. and Zarifian, E. (1980b). Science, 209, 303
Bunny, W.E. and Davis, J.M. (1965). Arch. Gen. Psychiat., 13, 483
Burt, D.R. (1978) In Neurotransmitter Receptor Binding, ed. H. I. Yamamura, S. J. Enna and M.J. Kuhar (Raven Press, New York ) p. 41
Clements-Jewery, S. (1978). Neuropharmacology 17, 779
Creese, I., Burt, D.R. and Snyder, S.H. (1975). Life Sci, 17, 993
Deleon-Jones, F., Mass, J.M., Dekirmenjian, H. and Sanchez, J. (1975). Am. J. Psychiat., 132, 1141
Goodwin, F.K. and Beckmann, H. (1975). Proc. Amer. Psychiat. Ass., 128, 96
Greenspan, K., Schildkraut, J.J., Gordon, E.K., Bar, L., Arnoff, M.S. and Durell, J. (1970). J. Psychiat. Res., 7, 171
Jones, R.S.G. (1978). Neuropharmacology 17, 771
Jones, R.S.G. and Roberts, M.H.T. (1978). Brit. J. Pharmacol., 65, 501
Jones, R.S.G. and Roberts, M.H.T. (1979). J. PharmacoL, 31, 87
Kinnier, W.J., Chuang, D.M., Farber, L. and Costa, E. (1980). Fed. Proc., 39, 1097
Langer, S.Z., Moret, C., Raisman, R., Dubocovich, M.L. and Briley, M. (1980a). Science, 210, 1133
Langer, S.Z., Raisman, R. and Briley, M. (1980b). Eur. J. Pharmacol., 64, 89
Langer, S.Z., Briley, M.S., Raisman, R., Henry, J.F. and Morselli, P.L. (1980c). Naunyn Schmiedeberger’s Arch. Pharma coL, 313, 189
Langer, S.Z., Javoy-Agiel, F., Raisman, R., Briley, M. and Agid, Y. (1981). J. Neurochem. (in press)
Lloyd, K.J., Farley, I.J., Deck, J.H.N. and Hornykiewicz, O. (1974). Adv. Biochem. Psychopharmaco, 11, 387
McMillen, B.A., Warnack, W., German, D.C. and Shore, P.A. (1980). Eur. J. PharmacoL, 61, 239
Maggi, A., U’Prichard, D.C., and Enna, S.J. (1980). Eur. J. Pharmaco, 61, 91
Mass, J.M., Fawcett, J.A. and Dekirmenjian, H. (1972). Arch. Gen. Psychiat., 26, 252
Minneman, K.P., Dibner, M.D., Wolfe, B.B. and Molinoff, P.B. (1979). Science 204, 866
Mogilnicka, E., Arbilla, S., Departere, H. and Langer, S.Z. (1980). Eur. J. PharmacoL, 65, 289
Mohler, H. and Okada, T. (1977). Life Sci., 20, 2101
Moses, S.G. and Robin, E. (1975). Psychopharmacol. Commun., 1, 327
O’Brien, R.A., Spirt, N.M. and Horst, W.D. (1978). Neuroscience Abstr., 4, 1366
Pandey, G.N., Heinze, W.J., Brown, B.D. and Davis, J.M. (1979a). Fed. Proc., 38, 592
Pandey, G.N., Dysken, M.W., Garver, D.L. and Davis, J.M. (1979b). Am. J. Psychiat., 136, 675
Pandey, G.N., Heinze, W.J., Brown, B. and Davis, J.M. (1979c). Nature 280, 234
Post, R.M., Gordon, E.K., Goodwin, F.K. and Bunney, W.E. (1973). Science 179, 1002
Raisman, R., Briley, M. and Langer, S.Z. (1979a). Eur. J. Pharmacol., 54, 307
Raisman, R., Briley, M. and Langer, S.Z. (1979b). Nature 281, 148
Iaisman, R., Briley, M. and Langer, S.Z. (1980). Eur. J. Pharmacol., 61, 373
Rehavi, M. and Sokolovsky, M. (1978). Brain. Res., 149, 525
Rosenblatt, J.E., Pert, C.B., Tallman, J.F., Pert, A. and Bunney, W.E. (1979). Brain Res., 160, 186
Sarai, K., Frazer, A., Brunswick, D. and Mendels, J. (1977). Biochem. Pharmacol., 27, 2179
Savage, D.D., Mendels, J. and Frazer, A. (1980). J. Pharmacol. Exp. Ther., 212, 259
Schildkraut, J.J. (1965). Am. J. Psychiat., 32, 509
Schweitzer, J.W., Schwartz, R. and Friedhoff, A.J. (1979). J. Neurochem., 33, 377
Segawa, T., Mizuta, T. and Nomura, Y. (1979). Eur. J. Pharmacol., 58, 75
Sellinger, M.M., Frazer, A. and Mendels, J. (1979). Neuroscience Abstr., 5, 1924
Sneddon, J.M. (1973). Progr. Neurobiol., 1, 153
Snyder, S.H. and Yamamura, H.I. (1977). Arch. Gen. Psychiat., 34, 236
Squires, R.F. and Braestrup, C. (1977). Nature, 266, 732
Stahl, S.M. (1977). Arch. Gen. Psychiat., 34, 509
Tang, S.W. and Seeman, P. (1979). Neurscience Abstr., 5, 353
Tran, V.T., Chang, R.S.L. and Snyder, S.H. (1978). Proc. Nat. Acad. Sci., 75, 6290
U’Prichard, D.C. and Enna, S.J. (1979). Eur. J. Pharmacol., 59, 297
Van Praag, H.M. (1974). Pharmacopsychiatry 7, 281
Van Praag, H.M. (1977). Biol. Psychiat., 12, 101
Vetulani, J. and Sulser, F. (1975). Nature 257, 495
Wehr, T. and Goodwin, F.K. (1977). In Handbook of Studies on Depression, ed. G.D. Burrows ( Excerpta Medica, Amsterdam ) p. 283
Wolfe, B.B., Harden, T.K., Sporn, J.R. and Molinoff, P.B. (1978). J. Pharmacol. Exp. Ther., 207, 446
Yamamura, H.I., Enna, S.J. and Kuhar, M.J. (1978). Neurotransmitter Receptor Binding ( Raven Press, New York )
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Pavel D. Hrdina and Radhey L. Singhal
About this chapter
Cite this chapter
Briley, M.S. (1981). Alteration in Brain Receptors in Affective Disorders. In: Hrdina, P.D., Singhal, R.L. (eds) Neuroendocrine Regulation and Altered Behaviour. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4067-6_14
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4067-6_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4069-0
Online ISBN: 978-1-4684-4067-6
eBook Packages: Springer Book Archive